On August 23, President of the Russian Federation Vladimir Putin launched the seventh International Military-Technical Forum “ARMY-2021”.
The forum is held annually at the Patriot Exhibition and Convention Center (Kubinka) and is the most authoritative platform demonstrating the advanced achievements of science and technology in the interests of the Armed Forces of the Russian Federation.
At the ARMY-2021 forum, Endopharm, subordinated to the Ministry of Industry and Trade of Russia, presents an exhibition exposition demonstrating the latest achievements of the enterprise in the field of development, production and quality control of medicines and medical devices.
In the first days of the forum, the active attention of specialists was attracted by the line of low molecular weight heparins developed and manufactured by Endopharm, used for the prevention of thromboembolic complications in the treatment of coronavirus infection, in single use pre-filled syringes.
The production of medicines in new dosage forms – in single use pre-filled syringes, with a capacity of 30 million units per year, is organized within the framework of the federal target program “Development of the pharmaceutical and medical industry of the Russian Federation for the period up to 2020 and further.” Reconstruction and technical re-equipment of production was carried out in strict compliance with international GMP standards, which allows us to meet the needs of the domestic healthcare system with high-quality import-substituting products, and also increases the export potential of the Enterprise.
Visitors to the exhibition exposition of the enterprise have noted the innovative potential of Endopharm in the field of development and production of reference samples. In the autumn of 2020, the Enterprise received accreditation for compliance with the requirements of the international standard ISO 17034:2016, confirming the scientific and technical competence to produce reference samples that meet international quality standards, taking into account modern requirements for the organization of the production process. The obtained accreditation allows Endopharm to use the Combined ILAC MRA mark on the certificates of produced reference samples in accordance with the scope of accreditation, which gives the documents weight abroad, as far as it indicates that it is issued by a manufacturer whose accreditation is internationally recognized.
The Forum participants highly appreciate the quality of disposable medical masks and Dezenda sanitizers produced by Endopharm. The production of medical masks, with a capacity of up to 4 million units per day (of which up to 2 million are sterile), was organized in 2020 according to a full cycle production using domestic raw materials: from the manufacture of high-tech filter material - meltblown, to components - nasal clips and elastic bands for ear loops. In November 2020, Endopharm received a CE declaration for medical disposable masks, type IIR, to confirm the compliance of the products with the requirements of EU directives.
Endopharm invites participants and guests of the ARMY-2021 forum to visit the company's exposition at exhibition stand 4B9-1, pavilion D. On August 24-25, the forum will be open to specialists in the military-technical field, on August 26-28, the exhibition exposition of the forum will be open to everyone.
Comment type is not specified in the component properties.